Elicio Therapeutics, Inc. (ELTX) Q4 2024 Annual Earnings
ELTX·Reported March 31, 2025·Before market open
Elicio Therapeutics, Inc. reported Q4 2024 revenue of $1.2M. Diluted EPS came in at $-1.02, missed the $-0.94 consensus by $0.08.
Revenue
$1.2M
Diluted EPS
$-1.02missed by $0.08
Consensus: $-0.94
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Elicio Therapeutics, Inc.'s Q4 2024 earnings report.
Elicio Therapeutics, Inc. (ELTX) reported Q4 2024 earnings on March 31, 2025 before market open.
Elicio Therapeutics, Inc. reported revenue of $1.2M and diluted EPS of $-1.02 for Q4 2024.
EPS missed the consensus estimate of $-0.94 by $0.08.
You can read the 10-K periodic report (0001601485-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.